Observational study describes the link between performance status and clinical outcomes in PCNSL treated with ibrutinib, indicating potential health implications.
To describe the association between performance status, clinical response, and overall survival (OS) in primary central nervous system lymphoma (PCNSL) patients treated with Ibrutinib.
No takes yet. Share an insight, caveat, or question.
Timilsena et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: